EFM
AVXL icon

E Fund Management’s Anavex Life Sciences AVXL Stock Holding History

E Fund Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,070
Closed -$55.5K – 494
2026
Q1 		$55.5K Buy
+18,070
New +$78.3K ﹤0.01% 487
2025
Q2 		$94.6K Sell
10,259
-1,652
-14% -$14.1K ﹤0.01% 377
2025
Q1 		$102K Buy
+11,911
New +$112K ﹤0.01% 382
2024
Q3 		– Sell
-13,623
Closed -$57.5K – 355
2024
Q2 		$57.5K Sell
13,623
-18,036
-57% -$73K ﹤0.01% 315
2024
Q1 		$161K Buy
31,659
+19,271
+156% +$108K 0.01% 358
2023
Q4 		$115K Sell
12,388
-1,520
-11% -$10.5K 0.01% 300
2023
Q3 		$91K Sell
13,908
-4,945
-26% -$39.4K 0.01% 286
2023
Q2 		$153K Sell
18,853
-7,561
-29% -$64.8K 0.01% 289
2023
Q1 		$226K Buy
26,414
+2,052
+8% +$20.5K 0.02% 275
2022
Q4 		$226K Buy
24,362
+5,547
+29% +$59.3K 0.02% 280
2022
Q3 		$194K Sell
18,815
-429
-2% -$4.53K 0.02% 309
2022
Q2 		$193K Buy
19,244
+777
+4% +$7.36K 0.02% 303
2022
Q1 		$227K Buy
+18,467
New +$227K 0.01% 272

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

E Fund Management's AVXL Position: Q2 2026 in Review

E Fund Management sold out of Anavex Life Sciences (AVXL) in Q2 2026, closing a stake of 18,070 shares — an estimated $55.5K sold.

E Fund Management first reported a position in AVXL in Q1 2022 and held it in 13 quarters. The position peaked at $227K in Q1 2022. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • E Fund Management reported no remaining Anavex Life Sciences position as of Q2 2026 after selling out during the quarter.
  • E Fund Management sold 18,070 Anavex Life Sciences shares in Q2 2026, an estimated $55.5K.
  • E Fund Management first reported a position in Anavex Life Sciences in Q1 2022 and held it in 13 quarters.
  • E Fund Management's Anavex Life Sciences position peaked at $227K in Q1 2022.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.